On September 4–5, 2026, the 8th CMC-CHINA China Pharmaceutical Industry Expo (CMC Pharma Expo) was grandly held at the Suzhou International Expo Centre. Yiling Pharmaceutical CO., LTD and Wanyang Hengshui Pharmaceutical CO., LTD jointly appeared at Booth C-C10, Hall C, and received two major awards at the expo’s awards ceremony: Yiling Pharma won the “Excellence Award for International Formulation CDMO,” while Wanyang Hengshui Pharmaceutical won the “Trusted Brand Award for API CDMO.” These two heavyweight industry honors fully recognize the outstanding contributions that Yiling Pharma and Wanyang have respectively made in the international formulation CDMO services and API CDMO fields.
The CMC Pharma Expo was hosted by Pharmcube, centered on industrial pharmaceutical companies, and is dedicated to building a full industrial-chain ecosystem expo covering the “R&D, production, and sales” of all links in the pharmaceutical industry. The expo brought together 24,000+ registered visitors and 350+ exhibitors to discuss frontier trends and cooperation opportunities in the pharmaceutical industry. The dual honors won by Yiling Pharma and Wanyang not only represent the industry’s high recognition of Yiling Pharma and Wanyang’s continued deep cultivation in the formulation and API CDMO, but also mark another milestone breakthrough for the company in its integrated API-to-formulation capabilities and full-chain international service capabilities.
During the expo, Yiling Pharma and Wanyang meticulously set up their booth, showcasing—through process explanations and material sharing—the complete industrial chain’s technical strength and full-dimension production capacity advantages spanning from high-grade intermediates and APIs to oral solid dosage forms and injections. At the same time, they actively participated in the expo’s dedicated roadshow sessions, systematically sharing with industry peers their integrated API-to-formulation CDMO/CMO platform capabilities, global cGMP quality systems, and domestic and overseas project cooperation models, fully demonstrating the company’s innovative service capabilities and attracting many partners to stop by for exchanges. The atmosphere was lively, laying a solid foundation for cooperation for subsequent project implementation, business docking, and market expansion.
Adhering to the philosophy of “Quality, Compliance, and Service,” Yiling Pharma and Wanyang have always been committed to providing global partners with high-quality, one-stop integrated API-to-formulation CDMO/CMO solutions. The two honors won this time represent the industry’s dual affirmation of the company’s technical strength, quality system, and service quality. Looking ahead, Yiling Pharma and Wanyang Hengshui Pharma remain committed to helping a growing number of partners navigate successful drug registrations and market entries worldwide. In doing so, we strive to drive the high-quality development of China’s pharmaceutical industry and make greater contributions to global healthcare.